Microwindows

Levi & Korsinsky, LLP and Pomerantz LLP Announce Proposed Settlement of Class Action Involving Purchasers of Nano-X Imaging Ltd. Securities

Retrieved on: 
Friday, December 1, 2023

The Court may adjourn or continue the Settlement Hearing or hold the Settlement Hearing by telephonic or video conference without further notice to members of the Settlement Class.

Key Points: 
  • The Court may adjourn or continue the Settlement Hearing or hold the Settlement Hearing by telephonic or video conference without further notice to members of the Settlement Class.
  • Any change to the Settlement Hearing date, time, or manner will be posted on the settlement website ( www.NanoXSettlement.com ).
  • The Settlement was reached on behalf of all Persons and entities who purchased or otherwise acquired Nano-X securities between August 21, 2020 and November 17, 2021, inclusive (the "Settlement Class").
  • This Summary Notice provides only a summary of matters regarding the Litigation and the Settlement.

Global AI-Based Medical Imaging Market Report 2022-2027: Increased Demand for AI Tools in the Medical Field & An Influx of Large and Complex Datasets Presents High Potential Opportunities

Retrieved on: 
Monday, July 25, 2022

The global AI based Medical Imaging market was valued at USD 764.44 million in the year 2021 with North America region leading the regional market share.

Key Points: 
  • The global AI based Medical Imaging market was valued at USD 764.44 million in the year 2021 with North America region leading the regional market share.
  • The report presents the analysis of AI based Medical Imaging Market for the historical period of 2017-2021 and the forecast period of 2022-2027.
  • The report analyses the AI based Medical Imaging Market Image acquisition technology (X-ray, Ultrasound, MRI, CT scan and others).
  • The Global AI based Medical Imaging Market has been analysed By Region (North America, Europe, Asia Pacific, Latin America and MEA).

Global AI-Based Medical Imaging Market Report 2022-2027: Growing Prevalence of Chronic Diseases & Technological Advancements in Medical Diagnosis Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, July 22, 2022

The global AI based Medical Imaging market was valued at USD 764.44 million in the year 2021 with North America region leading the regional market share.

Key Points: 
  • The global AI based Medical Imaging market was valued at USD 764.44 million in the year 2021 with North America region leading the regional market share.
  • Some of the key factors driving the AI based Medical Imaging market growth are growing prevalence of chronic diseases, rising geriatric population, technological advancements in medical diagnosis, increased demand for AI tools in the medical field, an influx of large and complex datasets and an increase in cross-industry partnerships and collaborations.
  • The report analyses the AI based Medical Imaging Market Image acquisition technology (X-ray, Ultrasound, MRI, CT scan and others).
  • The Global AI based Medical Imaging Market has been analysed By Region (North America, Europe, Asia Pacific, Latin America and MEA).

Lifshitz Law Firm, P.C. Announces Investigations of Bristol-Myers Squibb Company (NYSE: BMY), Eargo, Inc. (NASDAQGS: EAR), Hyzon Motors Inc. (NASDAQ: HYZN), Nano-X Imaging Ltd. (NASDAQ: NNOX), and View, Inc. (NASDAQGM: VIEW)

Retrieved on: 
Thursday, December 23, 2021

If you are a BMY investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.

Key Points: 
  • If you are a BMY investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.
  • If you are a Hyzon investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.
  • The law firm responsible for this advertisement is Lifshitz Law Firm, P.C., 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780.
  • Prior results do not guarantee or predict a similar outcome with respect to any future matter.

DEADLINE ALERT for EAR and NNOX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Monday, December 6, 2021

LOS ANGELES, Dec. 06, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • LOS ANGELES, Dec. 06, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
  • The Law Offices of Frank R. Cruz, Los Angeles

NANO-X DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Nano-X Imaging Ltd. and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, December 6, 2021

Investors have until December 6, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until December 6, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • On June 17, 2021, Nano-X submitted a 510(k) submission to the U.S. Food and Drug Administration (the "FDA") for its multi-source version of the Nanox.ARC.
  • Following this submission, defendants touted the Nanox.ARCs regulatory and commercial prospects in various public statements and U.S. Securities and Exchange Commission filings.
  • ARCs regulatory and commercial prospects; and (iv) consequently, Nano-Xs public statements were materially false and misleading at all relevant times.

NNOX FINAL DEADLINE MONDAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Nano-X Imaging Ltd. Investors to Secure Counsel Before Important December 6 Deadline in Securities Class Action – NNOX

Retrieved on: 
Saturday, December 4, 2021

WHAT TO DO NEXT: To join the Nano-X class action, go to http://www.rosenlegal.com/cases-register-2171.html or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Nano-X class action, go to http://www.rosenlegal.com/cases-register-2171.html or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

NNOX 2-DAY DEADLINE ALERT: Hagens Berman Encourages Nano-X Imaging (NNOX) Investors with Significant Losses to Contact Firm’s Attorneys Now, LEAD PLAINTIFF DEADLINE DEC. 6TH in Securities Fraud Lawsuit

Retrieved on: 
Saturday, December 4, 2021

The litigation alleges that Defendants misled investors concerning the 510(k) submission for Nanox.ARC.

Key Points: 
  • The litigation alleges that Defendants misled investors concerning the 510(k) submission for Nanox.ARC.
  • Were focused on investors losses and proving Nano-X mispresented Nanox.ARCs regulatory and commercial prospects, said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Nano-X Imaging and have significant losses, or have knowledge that may assist the firms investigation, click here to discuss your legal rights with Hagens Berman .
  • Hagens Berman is a national law firm with eight offices in eight cities around the country and over eighty attorneys.

NANO-X DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Nano-X Imaging Ltd. and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, December 4, 2021

Investors have until December 6, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until December 6, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • On June 17, 2021, Nano-X submitted a 510(k) submission to the U.S. Food and Drug Administration (the "FDA") for its multi-source version of the Nanox.ARC.
  • Following this submission, defendants touted the Nanox.ARCs regulatory and commercial prospects in various public statements and U.S. Securities and Exchange Commission filings.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

DEADLINE ALERT for EAR, NNOX, INNV, ZEV: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Friday, December 3, 2021

Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email to [email protected] .
  • Law Offices of Howard G. Smith